Related Experiment Video
Updated: May 6, 2026

09:17
Using Retinal Imaging to Study Dementia
Published on: November 6, 2017
22.4K
Association Between Retinal Vein Occlusion and Epiretinal Membrane Development.
Abdulkader Almosa1, Ahmed M Alshaikhsalama2, Ahmed Abdi2
1From the School of Medicine (A.A.), Texas Tech University Health Sciences Center, Lubbock, Texas, USA.
American Journal of Ophthalmology
|February 26, 2026
Summary
Retinal vein occlusion (RVO) significantly increases the risk of epiretinal membrane (ERM) formation within three months. Surgical intervention for ERM typically occurs later, with anti-VEGF treatment potentially delaying this timing.
Area of Science:
- Ophthalmology
- Retinal Diseases
- Vascular Disorders
Background:
- Retinal vein occlusion (RVO) is a significant cause of vision loss.
- Epiretinal membrane (ERM) formation can lead to visual distortion and decreased acuity.
- The relationship between RVO and subsequent ERM development requires further temporal analysis.
Purpose of the Study:
- To evaluate the temporal association between retinal vein occlusion (RVO) and the development of epiretinal membrane (ERM).
- To assess the timing of subsequent ERM peel surgery in RVO patients.
- To compare ERM development and peel timing in treated versus untreated RVO cohorts.
Main Methods:
- Retrospective cohort study utilizing a national clinical database.
- Propensity score matching (PSM) was applied to compare RVO patients (BRVO and CRVO) with matched controls.
- Relative risk (RR) of incident ERM formation and ERM peel was analyzed at multiple time points up to five years.
Main Results:
- Both BRVO and CRVO cohorts showed a significantly higher risk of ERM formation at three months post-RVO compared to controls (RR 4.54 and 4.90, respectively).
- ERM peel risk peaked at one year for BRVO (RR 3.83) and three years for CRVO (RR 3.91).
- Anti-VEGF treatment was associated with higher ERM rates at three months (BRVO-T RR 5.60, CRVO-T RR 6.80) and a later peak for ERM peel (5 years).
Conclusions:
- ERM typically forms within three months following RVO.
- Surgical intervention for ERM occurs later, with timing influenced by RVO type and anti-VEGF treatment.
- Treated RVO patients had an elevated ERM risk, potentially due to baseline disease severity.

